Financials

  • Market Capitalization 212.05 M
  • Employee 59
  • Founded 2019
  • CEO N/A
  • Website www.sionnatx.com
  • Headquarter Delaware, United States
  • FIGI BBG016X2DC85
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-21.88
Rapporto prezzo/fatturato
4 110.11

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3479
STRO
Sutro Biopharma, Inc. - Common Stock
13.28 USD-6.94%-12.29%-22.29%-23.63%220.20 M USD
3494
TRDA
Entrada Therapeutics, Inc. - Common Stock
5.50 USD-3.00%-0.36%-19.12%-21.09%214.15 M USD
3505
RNAC
Cartesian Therapeutics, Inc. - Common Stock
6.99 USD-0.99%-2.24%-14.65%-23.69%211.48 M USD
3519
NAGE
Niagen Bioscience, Inc. - Common Stock
2.63 USD-2.23%-1.50%-13.49%-47.19%208.10 M USD